FDA clearance for ‘revolutionary’ approach to J-Pouch issue
ExeGi Pharma LLC, which develops live biotherapeutic drugs and probiotics, says the FDA has cleared…
ExeGi Pharma LLC, which develops live biotherapeutic drugs and probiotics, says the FDA has cleared…
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the…
The World Health Organization (WHO) ranks antibiotic resistance as one of the top 10 threats…
A group of researchers from the Graduate School of Medicine at Nagoya University in Japan…
Atrogi AB, an early-stage Swedish pharma company, has announced that the first patient has been…
Sysnav Healthcare and Roche have partnered to develop industry standard outcome measurements in diseases associated…
Ibex Medical Analytics has announced an agreement with AstraZeneca and Daiichi Sankyo, for the development,…
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has…
Alcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due…
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101,…
Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new…
Medical research charity LifeArc, the Motor Neurone Disease Association (MND Association) and the My Name’5…